Erythropoietin, Modified to Not Stimulate Red Blood Cell Production, Retains Its Cardioprotective PropertiesChanil Moon, Mark I. Talan, Michael Brines et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 96
A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspanNolan M. Winicki, Edward G. Lakatta, Alay Nanavati et al.|Frontiers in Cardiovascular Medicine|2023Cited by 3